Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Empagliflozin improves outcomes for non-diabetic HFrEF patients

Treatment with empagliflozin for six months was associated with several key improvements. This suggests that, yes, SGLT2 inhibitors can be recommended for HFrEF patients who don't have diabetes. 

Thumbnail

COVID-related social isolation associated with high blood pressure

During a government-regulated lockdown in Argentina, patients admitted to the emergency department were much more likely to have high blood pressure. 

Thumbnail

Obese COVID-19 patients face a greater risk of in-hospital death, mechanical ventilation

“These observations support rigorous adherence to COVID-19 prevention strategies in obese individuals of all ages,” the researchers wrote. 

Face masks give no additional COVID defense to social distancing: Danish study

Mask wearers are no better defended against COVID-19 than their mask-shunning counterparts, according to a Danish study of almost 5,000 people, roughly half of whom wore face masks as COVID-19 protection in April and May.

Thumbnail

Transcatheter repair for tricuspid regurgitation is safe and effective

Transcatheter tricuspid valve repair consistently led to improved outcomes for patients with tricuspid regurgitation.

Thumbnail

Eating eggs can increase your risk of diabetes by up to 60%

The analysis, published in the British Journal of Nutrition, included more than 8,000 adults.

Fauci discusses the ongoing pandemic, social distancing, when a COVID-19 vaccine may be available and much more

Anthony S. Fauci, MD, a central figure in the White House Coronavirus Task Force, spoke at length about COVID-19 during the AHA's Scientific Sessions 2020 virtual meeting. 

$500K on the table in AI vs. COVID contest

Nonprofit competition organizer XPrize is partnering with global tech consultancy Cognizant to award AI innovators in a pandemic response challenge.